Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Gastrointestinal Stromal Tumors × Control Groups × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Anxiety Disorders 2 Unresectable Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Neoplasms 1 Gastrointestinal Stromal Tumors 1 Depression 1 Communication 1 Breast Neoplasms 1

Interventions

Imatinib Mesylate 2 regorafenib 1 pemigatinib 1 envafolimab 1 Control Groups 1 4-Aminopyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06772233 2025-07-31

A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

Peking University

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡